Ignite Creation Date:
2024-05-06 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05695976
Status:
RECRUITING
Last Update Posted:
2024-04-17
First Post:
2022-12-20
Brief Title:
GRETeL Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
Sponsor:
Organization:
Duke University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Tumor archival specimens will be obtained from the surgical resection and diagnosis of GBM and before initiation of radiotherapy It is anticipated that a certain proportion of patients will need to undergo further tumor debulking after radiotherapy In such instances these post-radiotherapy re-resected tumor specimens will also be collected for later sequencing
Enrollment Count:
100
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 91978 |
Who Masked List: